RIP1 regulates TNF-α-mediated lymphangiogenesis and lymphatic metastasis in gallbladder cancer by modulating the NF-κB-VEGF-C pathway

References

• KanthanRSAhmedJ-LKanthanSChandraSGallbladder cancer in the 21st centuryJ Oncol2015201596747226421012
   PubMed Web of Science ®Google Scholar
• ZhuAXHongTSHezelAFKoobyDACurrent management of gallbladder carcinomaOncologist201015216818120147507
   PubMed Web of Science ®Google Scholar
• LiuXYLaiFYanXGRIP1 kinase is an oncogenic driver in melanomaCancer Res20157581736174825724678
   PubMed Web of Science ®Google Scholar
• LaiCHLauWYGallbladder cancer – a comprehensive reviewSurgeon20086210111018488776
   PubMed Web of Science ®Google Scholar
• FuksDRegimbeauJMPessauxPIs port-site resection necessary in the surgical management of gallbladder cancer?J Visc Surg2013150427728423665059
   PubMed Web of Science ®Google Scholar
• CussonNOikemusSKilpatrickEDCunninghamLKelliherMThe death domain kinase RIP protects thymocytes from tumor necrosis factor receptor type 2–induced cell deathJ Exp Med20021961152612093867
   PubMed Web of Science ®Google Scholar
• Lei JiangFSChenYExpression of VEGF-C and VEGF-D and their correlation with lymphangiogenesis and angiogenesis in gallbladder carcinomaChin J Oncol2010323190195
   Google Scholar
• DuQJiangLWangXWangMSheFChenYTumor necrosis factor-alpha promotes the lymphangiogenesis of gallbladder carcinoma through nuclear factor-kappaB-mediated upregulation of vascular endothelial growth factor-CCancer Sci2014105101261127125154789
   PubMed Web of Science ®Google Scholar
• BrennerDBlaserHMakTWRegulation of tumour necrosis factor signalling: live or let dieNat Rev Immunol201515636237426008591
   PubMed Web of Science ®Google Scholar
• BalkwillFTumour necrosis factor and cancerNat Rev Cancer20099536137119343034
   PubMed Web of Science ®Google Scholar
• SilkeJThe regulation of TNF signalling: what a tangled web we weaveCurr Opin Immunol201123562062621920725
   PubMed Web of Science ®Google Scholar
• CroftMBenedictCAWareCFClinical targeting of the TNF and TNFR superfamiliesNat Rev Drug Discov201312214716823334208
   PubMed Web of Science ®Google Scholar
• ChristoffersonDELiYYuanJControl of life-or-death decisions by RIP1 kinaseAnnu Rev Physiol20147612915024079414
   PubMed Web of Science ®Google Scholar
• HaasTLEmmerichCHGerlachBRecruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene inductionMol Cell200936583184420005846
   PubMed Web of Science ®Google Scholar
• OfengeimDYuanJRegulation of RIP1 kinase signalling at the crossroads of inflammation and cell deathNat Rev Mol Cell Biol2013141172773624129419
   PubMed Web of Science ®Google Scholar
• HongHJiangLLinYTNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathwayBMC Cancer20161624026992854
   PubMed Web of Science ®Google Scholar
• ChenYJiangLSheFVascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanismMol Cell Biochem20103451–2778920734221
   PubMed Web of Science ®Google Scholar
• ZhuGChenXWangXExpression of the RIP-1 gene and its role in growth and invasion of human gallbladder carcinomaCell Physiol Biochem20143441152116525277242
   PubMedGoogle Scholar
• ZhuGThe Roles and Mechanisms of RIP1 Promote the Proliferation, Invasion and Matastasis of Gallbladder Carcinoma [doctor dissertation]Fujian Medical University2015Fuzhou, People’s republic of China
   Google Scholar
• ZengYOpeskinKGoadJWilliamsEDTumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasisCancer Res200666199566957517018613
   PubMed Web of Science ®Google Scholar
• DuQJiangLWangX-QPanWSheF-FChenY-LEstablishment of and comparison between orthotopic xenograft and subcutaneous xenograft models of gallbladder carcinomaAsian Pac J Cancer Prev20141583747375224870787
   PubMedGoogle Scholar
• ChoYSChallaSMoquinDPhosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammationCell200961213711121123
   Google Scholar
• AdrianTTing FXP-MaBS. RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosisEMBO J19961522618961968947041
   PubMed Web of Science ®Google Scholar
• RistimäkiANarkoKEnholmBJoukovVAlitaloKProinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-CJ Biol Chem19982731484139525952
   PubMed Web of Science ®Google Scholar
• ChaHSBaeEKKohJHTumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytesJ Rheumatol2007341161917216674
   PubMed Web of Science ®Google Scholar
• HaiJieHCaiLongHSiYuanZCCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the “ERK1/2–AP-1” and “JNK–AP-1” pathwaysJ Exp Clin Cancer Res20163515127009073
   PubMed Web of Science ®Google Scholar
• JiHCaoRYangYTNFR1 mediates TNF-alpha-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signallingNat Commun20145494425229256
   PubMed Web of Science ®Google Scholar
• KimuraHMikamiDKamiyamaKTelmisartan, a possible PPAR-delta agonist, reduces TNF-alpha-stimulated VEGF-C production by inhibiting the p38MAPK/HSP27 pathway in human proximal renal tubular cellsBiochem Biophys Res Commun2014454232032725450396
   PubMed Web of Science ®Google Scholar
• ShojaeiFAnti-angiogenesis therapy in cancer: current challenges and future perspectivesCancer Lett2012320213013722425960
   PubMed Web of Science ®Google Scholar
• EbosJMKerbelRSAntiangiogenic therapy: impact on invasion, disease progression, and metastasisNat Rev Clin Oncol20118421022121364524
   PubMed Web of Science ®Google Scholar
• KatsiVKPsarrosCTKrokidisMGAnti-angiogenic therapy and cardiovascular diseases: current strategies and future perspectivesAnti Angiog Drug Discov Dev20142143
   Google Scholar
• HumphriesFYangSWangBMoynaghPNRIP kinases: key decision makers in cell death and innate immunityCell Death Differ201522222523625146926
   PubMed Web of Science ®Google Scholar
• FilliolAPiquet-PellorceCLe SeyecJRIPK1 protects from TNF-alpha-mediated liver damage during hepatitisCell Death Dis2016711e246227831558
   PubMed Web of Science ®Google Scholar
• WongWWGentleIENachburUAndertonHVauxDLSilkeJRIPK1 is not essential for TNFR1-induced activation of NF-kappaBCell Death Differ201017348248719927158
   PubMed Web of Science ®Google Scholar
• SunJYuXWangCRIP-1/c-FLIPL induce hepatic cancer cell apoptosis through regulating tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)Med Sci Monit2017231190119928270653
   PubMed Web of Science ®Google Scholar
• CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
   PubMed Web of Science ®Google Scholar
• ZhangHZhouXMcQuadeTLiJChanFK-MZhangJCorrigendum: functional complementation between FADD and RIP1 in embryos and lymphocytesNature20124837390498
   Web of Science ®Google Scholar
• ZhangJZhangHLiJRIP1-mediated regulation of lymphocyte survival and death responsesImmunol Res2011512–322723622038529
   PubMed Web of Science ®Google Scholar
• LuanQJinLJiangCCRIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagyAutophagy201511797599426018731
   PubMed Web of Science ®Google Scholar
• BistPLeowSCPhuaQHAnnexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-kappaB: implication in breast cancer metastasisOncogene201130283174318521383699
   PubMed Web of Science ®Google Scholar
• MacarthurMHoldGLEl-OmarEMInflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancyAm J Physiol Gastrointest Liver Physiol20042864G515G52015010360
   PubMed Web of Science ®Google Scholar
• ZhouLSShiJSWangZRWangLExpression of tumor necrosis factor in gallstone and gallbladder carcinoma tissueCarcinog Teratog Mutagen2000123139142
   Google Scholar
• ParkSHatanpaaKJXieYThe receptor interacting protein 1 inhibits p53 induction through NF-κB activation and confers a worse prognosis in glioblastomaCancer Res20096972809281619339267
   PubMed Web of Science ®Google Scholar